A candidate therapeutic vaccine for chronic hepatitis C infection based on envelope 1 protein: Tolerability and immunogenicity in healthy adult volunteers.

被引：0
|
作者：
Leroux-Roels, GG
Depla, E
Hulstaert, F
De Smedt, J
Desombere, I
Maertens, G
机构：
[1] State Univ Ghent, B-9000 Ghent, Belgium
[2] Innogenetics, Ghent, Belgium
[3] Regipharm, Brussels, Belgium
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1110
引用
收藏
页码：449A / 449A
页数：1
相关论文
共 50 条
  • [1] A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers
    Leroux-Roels, G
    Depla, E
    Hulstaert, F
    Tobback, L
    Dincq, S
    Desmet, J
    Desombere, I
    Maertens, G
    VACCINE, 2004, 22 (23-24) : 3080 - 3086
  • [2] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A CANDIDATE VACCINE IN HEALTHY ADULT VOLUNTEERS
    WIEDERMANN, G
    AMBROSCH, F
    KOLLARITSCH, H
    HOFMANN, H
    KUNZ, C
    DHONDT, E
    DELEM, A
    ANDRE, FE
    SAFARY, A
    STEPHENNE, J
    VACCINE, 1990, 8 (06) : 581 - 584
  • [3] Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection
    Leroux-Roels, Geert
    Batens, Arsene-Helene
    Desombere, Isabelle
    Van den Steen, Bart
    Stichele, Christine Vander
    Maertens, Geert
    Hulstaert, Frank
    HUMAN VACCINES, 2005, 1 (02): : 61 - 65
  • [4] SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY ADULT VOLUNTEERS
    HORNG, YC
    CHANG, MH
    LEE, CY
    SAFARY, A
    ANDRE, FE
    CHEN, DS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (04) : 338 - 341
  • [5] IMMUNOGENICITY AND TOLERABILITY OF NOVEL HUMAN PAPILLOMAVIRUS-16/18 VACCINE IN HEALTHY MALE VOLUNTEERS.
    Kim, Y.
    Shin, D.
    Lee, S.
    Oh, J.
    Han, J.
    Lee, N.
    Lee, H.
    Yu, K.
    Chung, J.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S82 - S83
  • [6] Safety, Tolerability and Immunogenicity of GS-4774, an HBV-specific Therapeutic Vaccine, in Healthy Volunteers
    Gaggar, Anuj
    Coeshott, Claire
    Subramanian, Mani
    McHutchison, John G.
    Apelian, David
    HEPATOLOGY, 2013, 58 : 656A - 656A
  • [7] CLINICAL-TRIAL OF A LYOPHILIZED INACTIVATED HEPATITIS-A CANDIDATE VACCINE IN HEALTHY ADULT VOLUNTEERS
    IINO, S
    FUJIYAMA, S
    HORIUCHI, K
    JYO, K
    KUWABARA, Y
    SATO, S
    SAIKA, S
    MORITA, M
    ODOH, K
    KUZUHARA, S
    WATANABE, H
    TANAKA, M
    MIZUNO, K
    VACCINE, 1992, 10 (05) : 323 - 328
  • [8] In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
    Vasan, Sandhya
    Hurley, Arlene
    Schlesinger, Sarah J.
    Hannaman, Drew
    Gardiner, David F.
    Dugin, Daniel P.
    Boente-Carrera, Mar
    Vittorino, Roselle
    Caskey, Marina
    Andersen, Johanne
    Huang, Yaoxing
    Cox, Josephine H.
    Tarragona-Fiol, Tony
    Gill, Dilbinder K.
    Cheeseman, Hannah
    Clark, Lorna
    Dally, Len
    Smith, Carol
    Schmidt, Claudia
    Park, Harriet H.
    Kopycinski, Jakub T.
    Gilmour, Jill
    Fast, Patricia
    Bernard, Robert
    Ho, David D.
    PLOS ONE, 2011, 6 (05):
  • [9] In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers
    Vasan, S.
    Hurley, A.
    Schlesinger, S. J.
    Hannaman, D.
    Gardiner, D. F.
    Dugin, D. P.
    Boente-Carrera, M. M.
    Vittorino, R. M.
    Caskey, M.
    Andersen, J.
    Huang, Y.
    Cox, J.
    Tarragona, T.
    Gill, D. K.
    Cheeseman, H.
    Clark, L.
    Dally, L.
    Smith, C.
    Schmidt, C.
    Park, H.
    Sayeed, E.
    Gilmour, J.
    Fast, P.
    Bernard, R.
    Ho, D. D.
    RETROVIROLOGY, 2009, 6
  • [10] Multicenter study of safety and immunogenicity of HIV-1 rgp160 candidate vaccine in seropositive HIV-1 volunteers.
    Goebel, FD
    Mannhalter, JW
    Eibl, MM
    Belshe, RB
    Grob, P
    Erfle, V
    Griffiths, PD
    Wahren, B
    Krohn, K
    Kunschak, M
    Engl, W
    AIDS, 1996, 10 : OP64 - OP64
12345